The Cooper Companies, Inc.
COO
Pozycja w akcjach
#1932
The Cooper Companies, Inc. (COO) operates as a global medical device firm,... The Cooper Companies, Inc. (COO) operates as a global medical device firm, primarily focused on developing, producing, and distributing products through two distinct business units: CooperVision and CooperSurgical. CooperVision specializes in contact lenses. Their product range includes spherical lenses for common vision issues like nearsightedness and farsightedness, as well as advanced lenses such as toric for astigmatism, multifocal for presbyopia, and specialized options addressing myopia, dry eyes, and eye fatigue. These vision correction solutions are available across the Americas, Europe, the Middle East, Africa, and the Asia Pacific region. Meanwhile, CooperSurgical is dedicated to women's and family health, providing a wide array of medical devices, fertility treatments, genetic testing, diagnostic tools, and contraceptives to healthcare providers and patients globally. This segment's offerings encompass various surgical and office-based products like PARAGARD (an IUD), uterine manipulators, retractors, and closure devices. It also delivers comprehensive fertility services, including specialized consumables, equipment, embryo services, and preimplantation genetic screening. Established in 1958, The Cooper Companies, Inc. is headquartered in San Ramon, California.
Cena akcji
$57.50
Ostatnia synchronizacja: 2026-10-16
Kapitalizacja rynkowa
$10.93B
Zmiana (1 dzień)
0.17%
Zmiana (1 rok)
-20.11%
Kraj
US
Handel The Cooper Companies, Inc. (COO)
Kategoria
Healthcare
Marża operacyjna dla The Cooper Companies, Inc. (COO)
Marża operacyjna na dzień October 2026 TTM: 12.85%
Według najnowszych raportów finansowych i ceny akcji The Cooper Companies, Inc., bieżąca marża operacyjna (TTM) wynosi 12.85%. Na koniec 2024 wynosiła 18.12%.
Historia marży operacyjnej dla The Cooper Companies, Inc. od 2000 do 2026
Marża operacyjna na koniec każdego roku
| Rok | Marża operacyjna | Zmień |
|---|---|---|
| 2026 (TTM) | 12.85% | -23.01% |
| 2025 | 16.69% | -7.89% |
| 2024 | 18.12% | 22.10% |
| 2023 | 14.84% | -3.26% |
| 2022 | 15.34% | -11.38% |
| 2021 | 17.31% | 34.92% |
| 2020 | 12.83% | -37.72% |
| 2019 | 20.60% | 29.40% |
| 2018 | 15.92% | -20.64% |
| 2017 | 20.06% | 21.72% |
| 2016 | 16.48% | 25.13% |
| 2015 | 13.17% | -26.18% |
| 2014 | 17.84% | -7.42% |
| 2013 | 19.27% | -1.73% |
| 2012 | 19.61% | 14.68% |
| 2011 | 17.10% | 4.33% |
| 2010 | 16.39% | 18.17% |
| 2009 | 13.87% | 16.16% |
| 2008 | 11.94% | 147.72% |
| 2007 | 4.82% | -63.32% |
| 2006 | 13.14% | -21.97% |
| 2005 | 16.84% | -29.30% |
| 2004 | 23.82% | 2.98% |
| 2003 | 23.13% | 8.90% |
| 2002 | 21.24% | -9.00% |
| 2001 | 23.34% | -1.73% |
| 2000 | 23.75% | 0.00% |
Marża operacyjna dla podobnych firm lub konkurentów
| Firma | Marża operacyjna | Różnica w marży operacyjnej | Kraj |
|---|---|---|---|
| 31.28% | -97.57% |
US
|
|
| 12.36% | -99.04% |
FR
|
|
| 0.00% | - |
JP
|
|
| 9.83% | -99.24% |
US
|
|
| 0.00% | - |
CH
|
Czym jest marża operacyjna firmy?
Marża operacyjna to kluczowy wskaźnik do oceny rentowności firmy. Wyższe marże operacyjne są zazwyczaj korzystniejsze, ponieważ pokazują, że firma może sprzedawać swoje produkty lub usługi znacznie drożej niż koszty ich produkcji. Oblicza się ją, dzieląc zysk firmy przez jej przychody.